{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T03:05:55Z","timestamp":1773975955840,"version":"3.50.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100005625","name":"RSNA Medical Student Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005625","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BTG"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jvir.2018.08.010","type":"journal-article","created":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T00:09:44Z","timestamp":1539648584000},"page":"1646-1653.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Irinotecan-Eluting 75\u2013150-\u03bcm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study"],"prefix":"10.1016","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2519-5137","authenticated-orcid":false,"given":"Arash","family":"Fereydooni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Letzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mansur A.","family":"Ghani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milena A.","family":"Miszczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steffen","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julius","family":"Chapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd","family":"Schlachter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Francois","family":"Geschwind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christos","family":"Georgiades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2018.08.010_bib1","unstructured":"National Comprehensive Cancer Network. Colon Cancer. Version 2.2017. 2017. Available at: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/colon.pdf. Accessed October 10, 2018."},{"key":"10.1016\/j.jvir.2018.08.010_bib2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1634\/theoncologist.6-1-81","article-title":"Irinotecan plus fluorouracil\/leucovorin for metastatic colorectal cancer: a new survival standard","volume":"6","author":"Saltz","year":"2001","journal-title":"Oncologist"},{"key":"10.1016\/j.jvir.2018.08.010_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1245\/s10434-010-1288-5","article-title":"Hepatic intra-arterial injection of drug-eluting bead, irinotecan (DEBIRI) in unresectable colorectal liver metastases refractory to systemic chemotherapy: results of multi-institutional study","volume":"18","author":"Martin","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2018.08.010_bib4","first-page":"3413","article-title":"Early experience with 70\u2013150 \u03bcm irinotecan drug-eluting Beads (M1-DEBIRI) for the treatment of unresectable hepatic colorectal metastases","volume":"36","author":"Akinwande","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jvir.2018.08.010_bib5","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s00270-016-1537-5","article-title":"Review of the clinical evidence for the use of DEBIRI in the treatment of colorectal metastatic disease","volume":"40","author":"Young","year":"2017","journal-title":"Cardiovacs Intervent Radiol"},{"key":"10.1016\/j.jvir.2018.08.010_bib6","first-page":"1387","article-title":"Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study","volume":"32","author":"Fiorentini","year":"2012","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jvir.2018.08.010_bib7","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/j.jvir.2008.06.008","article-title":"Distribution of iron oxide\u2013containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy","volume":"19","author":"Lee","year":"2008","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2018.08.010_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10856-015-5629-6","article-title":"DC BeadM1: toward an optimal transcatheter hepatic tumour therapy","volume":"27","author":"Lewis","year":"2015","journal-title":"J\u00a0Mater Sci Mater Med"},{"key":"10.1016\/j.jvir.2018.08.010_bib9","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jhep.2011.03.024","article-title":"Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants","volume":"55","author":"Namur","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2018.08.010_bib10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1054\/bjoc.1999.1033","article-title":"Plasma vascular endothelial but not fibroblast growth factor levels correlate with colorectal liver\u00a0metastasis vascularity and volume","volume":"82","author":"Davies","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jvir.2018.08.010_bib11","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1245\/ASO.2006.03.060","article-title":"Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases","volume":"13","author":"Yoon","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jvir.2018.08.010_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1572-0241.1998.00249.x","article-title":"Circulating vascular endothelial growth factor in patients with colorectal cancer","volume":"93","author":"Fujisaki","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jvir.2018.08.010_bib13","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1200\/JCO.2015.61.9569","article-title":"Cost-Effectiveness Analysis of Regorafenib for Metastatic Colorectal Cancer","volume":"33","author":"Goldstein","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2018.08.010_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12032-017-0890-9","article-title":"Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization","volume":"34","author":"Scevola","year":"2017","journal-title":"Med Oncol"},{"key":"10.1016\/j.jvir.2018.08.010_bib15","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1002\/cncr.29534","article-title":"Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis","volume":"121","author":"Martin","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2018.08.010_bib16","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s11605-012-1892-8","article-title":"Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial","volume":"16","author":"Martin","year":"2012","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.jvir.2018.08.010_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4251\/wjgo.v7.i6.47","article-title":"Locoregional therapy and systemic cetuximab to treat\u00a0colorectal liver metastases","volume":"7","author":"Fiorentini","year":"2015","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.jvir.2018.08.010_bib18","first-page":"7239","article-title":"Concomitant capecitabine with hepatic delivery of drug eluting beads in metastatic colorectal cancer","volume":"34","author":"Akinwande","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jvir.2018.08.010_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jvir.2011.10.019","article-title":"Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine","volume":"23","author":"Dreher","year":"2012","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2018.08.010_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00270-014-1011-1","article-title":"Small versus large-sized drug-eluting beads (DEBIRI) for the treatment of hepatic colorectal metastases: a propensity score matching analysis","volume":"38","author":"Akinwande","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2018.08.010_bib21","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00270-015-1080-9","article-title":"Trans-arterial chemoembolization with irinotecan-loaded drug-eluting beads (DEBIRI) and capecitabine in refractory liver prevalent colorectal metastases: a phase II single-center study","volume":"38","author":"Iezzi","year":"2015","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2018.08.010_bib22","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1097\/COC.0000000000000151","article-title":"Yttrium-90 radioembolization as salvage therapy for liver metastases from colorectal cancer","volume":"40","author":"Kalva","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.jvir.2018.08.010_bib23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.clcc.2011.12.002","article-title":"Yttrium-90 radioembolization as salvage therapy for colorectal cancer with liver metastases","volume":"11","author":"Martin","year":"2012","journal-title":"Clin Colorectal Cancer"},{"key":"10.1016\/j.jvir.2018.08.010_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13550-016-0236-1","article-title":"Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response","volume":"6","author":"Rosenbaum","year":"2016","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.jvir.2018.08.010_bib25","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1007\/s00270-011-0234-7","article-title":"Matched-pair comparison of radioembolization plus best supportive care versus best supportive care alone for chemotherapy refractory liver-dominant colorectal metastases","volume":"35","author":"Seidensticker","year":"2012","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2018.08.010_bib26","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3892\/ijo.2012.1572","article-title":"First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI)","volume":"41","author":"Eichler","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jvir.2018.08.010_bib27","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1007\/s11605-012-1892-8","article-title":"Irinotecan drug-eluting beads in the treatment of chemo-naive unresectable colorectal liver metastasis with concomitant systemic fluorouracil and oxaliplatin: results of pharmacokinetics and phase I trial","volume":"16","author":"Martin","year":"2012","journal-title":"J\u00a0Gastrointest Surg"},{"key":"10.1016\/j.jvir.2018.08.010_bib28","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1111\/j.1349-7006.2008.00909.x","article-title":"Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients","volume":"99","author":"Hyun","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1016\/j.jvir.2018.08.010_bib29","first-page":"1539","article-title":"The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE)","volume":"91","author":"Leelawat","year":"2008","journal-title":"J\u00a0Med Assoc Thai"},{"key":"10.1016\/j.jvir.2018.08.010_bib30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/cdd.2009.152","article-title":"VEGF-dependent tumor angiogenesis requires the inverse and reciprocal regulation of VEGFR1 and VEGFR2","volume":"17","author":"Zhang","year":"2010","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jvir.2018.08.010_bib31","doi-asserted-by":"crossref","first-page":"e0131445","DOI":"10.1371\/journal.pone.0131445","article-title":"The role of vascular endothelial growth factor receptor-1 signaling in the recovery from ischemia","volume":"10","author":"Amano","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jvir.2018.08.010_bib32","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/s12885-015-1648-4","article-title":"Angiogenesis-related protein expression in bevacizumab-treated metastatic colorectal cancer: NOTCH1 detrimental to overall survival","volume":"15","author":"Paiva","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jvir.2018.08.010_bib33","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1200\/JCO.2012.46.2762","article-title":"Markers of response for the antiangiogenic agent bevacizumab","volume":"31","author":"Lambrechts","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2018.08.010_bib34","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejca.2008.10.027","article-title":"Individual patient data analysis to assess modifications to the RECIST criteria","volume":"45","author":"Bogaerts","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jvir.2018.08.010_bib35","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/1078-0432.CCR-12-2721","article-title":"Number of target lesions for EASL and modified RECIST to predict survivals in hepatocellular carcinoma treated with chemoembolization","volume":"19","author":"Kim","year":"2013","journal-title":"Clin Cancer Res"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044318314179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044318314179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T11:10:44Z","timestamp":1720696244000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044318314179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1051044318314179"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2018.08.010","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Irinotecan-Eluting 75\u2013150-\u03bcm Embolics Lobar Chemoembolization in Patients with Colorectal Cancer Liver Metastases: A Prospective Single-Center Phase I Study","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2018.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2018","name":"copyright","label":"Copyright"}]}}